RxDoctor Payments Data

Shabana Jessani

Developmental - Behavioral Pediatrics · Chandler, AZNPI 1437277795

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $23,500 of the $31,412 with a category attached, or 74.8%. Tris Pharma Inc accounts for 94.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $12,604 and has fallen 99.9% since, to $18 in 2025.

$31,412in general payments, 2019–2025

Across 210 payments — averaging $149.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tris Pharma Inc$30K
  • Neos Therapeutics, LP$316
  • Corium, LLC$312
  • Takeda Pharmaceuticals U.S.A., Inc.$271
  • Supernus Pharmaceuticals, Inc.$235
  • Ironshore Pharmaceuticals Inc.$163
  • plus $368 from 7 others

What the payments were for

  • Speaking & faculty fees$23,50075%
  • Travel & lodging$3,42511%
  • Food & beverage$4,46714%
  • Gifts$200%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few developmental - behavioral pediatrics providers in Arizonato place this figure against a meaningful peer group, so we don't.

Other developmental - behavioral pediatrics in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →